In 49 patients with lupus nephritis in clinical remission and asymptomatic serological reactivation, a pre-emptive moderate rise in immunosuppression vs observation gave 24-month kidney flare-free survival of 100% vs 80%; adverse events were few and similar.
RCTn = 49
Yap et al. A prospective multicenter randomized controlled trial pre-emptive increase in immunosuppression for asymptomatic serological reactivation in patients with lupus nephritis in clinical remission